| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| GRB7 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300330 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 28A (interferon, lambda 2) (IL28A). from ORIGENE TECHNOLOGIES | TP723166 | 20 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 28A (interferon, lambda 2) (IL28A), full length from ORIGENE TECHNOLOGIES | TP760751 | 50 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 1, alpha (IL1A) from ORIGENE TECHNOLOGIES | TP720056 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 1, alpha (IL1A) from ORIGENE TECHNOLOGIES | TP723707 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 1, alpha (IL1A). from ORIGENE TECHNOLOGIES | TP723206 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 23, alpha subunit p19 (IL23A). from ORIGENE TECHNOLOGIES | TP723221 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 23, alpha subunit p19 (IL23A) from ORIGENE TECHNOLOGIES | TP723732 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) (IL12A) from ORIGENE TECHNOLOGIES | TP723721 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) (IL12A) from ORIGENE TECHNOLOGIES | TP721240 | 10 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 23, alpha subunit p19 (IL23A) from ORIGENE TECHNOLOGIES | TP309680 | 20 ug | ORIGENE TECHNOLOGIES |
| Human interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) (IL12A). from ORIGENE TECHNOLOGIES | TP723184 | 10 ug | ORIGENE TECHNOLOGIES |
| CIC - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415209 | 1 kit | ORIGENE TECHNOLOGIES |
| Cic - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503347 | 1 kit | ORIGENE TECHNOLOGIES |
| PHC2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412697 | 1 kit | ORIGENE TECHNOLOGIES |
| PHC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422530 | 1 kit | ORIGENE TECHNOLOGIES |
| PHC3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417729 | 1 kit | ORIGENE TECHNOLOGIES |
| Phc2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513192 | 1 kit | ORIGENE TECHNOLOGIES |
| Phc1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513191 | 1 kit | ORIGENE TECHNOLOGIES |
| Phc3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN513193 | 1 kit | ORIGENE TECHNOLOGIES |
| Mouse CCL17/TARC ELISA Kit from ORIGENE TECHNOLOGIES | EA100437 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |
| Mouse CCL1/TCA3 ELISA Kit from ORIGENE TECHNOLOGIES | EA100390 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |
| CIAPIN1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409626 | 1 kit | ORIGENE TECHNOLOGIES |
| Ciapin1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503341 | 1 kit | ORIGENE TECHNOLOGIES |
| CIAPIN1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309626 | 10 ug | ORIGENE TECHNOLOGIES |
| Ciart - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503342 | 1 kit | ORIGENE TECHNOLOGIES |
| CIB1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401591 | 1 kit | ORIGENE TECHNOLOGIES |
| CIB4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414510 | 1 kit | ORIGENE TECHNOLOGIES |
| CIB3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416582 | 1 kit | ORIGENE TECHNOLOGIES |
| Cib1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503343 | 1 kit | ORIGENE TECHNOLOGIES |
| CIB2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407986 | 1 kit | ORIGENE TECHNOLOGIES |
| Human BH3 interacting domain death agonist (BID), transcript variant 2 from ORIGENE TECHNOLOGIES | TP720087 | 10 ug | ORIGENE TECHNOLOGIES |
| Human BH3 interacting domain death agonist (BID), transcript variant 2 from ORIGENE TECHNOLOGIES | TP307261 | 20 ug | ORIGENE TECHNOLOGIES |
| Human BH3 interacting domain death agonist (BID), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760319 | 50 ug | ORIGENE TECHNOLOGIES |
| Human SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) (SPC25), full length from ORIGENE TECHNOLOGIES | TP760096 | 50 ug | ORIGENE TECHNOLOGIES |
| Human SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) (SPC24) from ORIGENE TECHNOLOGIES | TP311241 | 20 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 1 subunit (CACNB1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424552 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 1 subunit (CACNB1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403703 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 1 subunit (CACNB1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404593 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430887 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404479 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424553 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404474 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 5 from ORIGENE TECHNOLOGIES | LY404477 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 4 from ORIGENE TECHNOLOGIES | LY404480 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 6 from ORIGENE TECHNOLOGIES | LY404469 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 7 from ORIGENE TECHNOLOGIES | LY404468 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 4 subunit (CACNB4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423647 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 4 subunit (CACNB4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400240 | 100 ug | ORIGENE TECHNOLOGIES |
| Calcium channel, voltage-dependent, beta 4 subunit (CACNB4), transcript variant 4 from ORIGENE TECHNOLOGIES | LY429012 | 100 ug | ORIGENE TECHNOLOGIES |